Diagnos Laboratorium Utama Tbk. vs Isra Presisi Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Isra Presisi Indonesia Tbk. trades at Rp24 (market cap 96.49B, 28.27M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 3.2× Isra Presisi Indonesia Tbk.'s market cap, and Isra Presisi Indonesia Tbk. is more actively traded (28.27M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | ISAP | |
|---|---|---|
Market Cap | 310.75B | 96.49B |
Volume | 963.6K | 28.27M |
Lot | 9.64K | 282.73K |
Turnover | 217.67M | 679.8M |
Average Price | 225.89 | 24.04 |
Value | 217.67M | 679.8M |
Indicative Equilibrium Price | 226 | 24 |
Indicative Equilibrium Volume | 1K | 2.42K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Isra Presisi Indonesia Tbk ("The Company") was established on October 22, 2011 based on Notary Deed No. 47 of Evi Nursamsiyati, S.H. The Company started its commercial operations in2011.
Read more on ISAP →